Clinical Trials · NCT02898506
Incretin-based Therapy in Late Preclinical Type 1 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Oulu
- Enrollment
- 13
- Start date
- Mar 2016
- Locations
- 4 sites, Finland, Sweden
- Primary endpoint
- FPIR (1+3min serum insulin level after iv glucose infusion)